{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:03:11Z","timestamp":1785402191887,"version":"3.56.0"},"reference-count":77,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy of Craiova, Romania"},{"id":[{"id":"https:\/\/ror.org\/031d5vw30","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Paraneoplastic endocrine syndromes (PESs) are hormonal disturbances associated with malignancies that result from tumor-related production of hormone-like substances, immune-mediated mechanisms, or dysregulated signaling pathways. While they are well recognized in lung and neuroendocrine cancers, their relevance in gastrointestinal tumors remains less clearly defined. This narrative review synthesizes current knowledge on paraneoplastic endocrine manifestations in gastrointestinal malignancies, based on a structured search of the literature in major databases, including PubMed, Scopus, and Web of Science. The analysis focuses on clinically relevant syndromes such as hypercalcemia, Cushing-like manifestations, disorders of water balance, hypoglycemia, and acromegaly, with emphasis on underlying mechanisms, associated tumor types, diagnostic approaches, and therapeutic considerations. Available evidence indicates that gastrointestinal tumors can produce a range of biologically active substances, leading to diverse endocrine manifestations that may precede tumor detection and influence disease course. Among these, hypercalcemia and Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) are among the most frequently reported, while other syndromes, such as ectopic Cushing syndrome or tumor-related hypoglycemia, are less common but often associated with more severe clinical outcomes. Recognition of these manifestations has direct clinical implications, as they may support earlier diagnosis, contribute to prognostic assessment, and guide therapeutic management. Improved awareness and a multidisciplinary approach remain essential for optimizing outcomes in patients with gastrointestinal malignancies.<\/jats:p>","DOI":"10.3390\/ijms27114677","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:14:52Z","timestamp":1779452092000},"page":"4677","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Endocrine Changes in Gastrointestinal Tumors: A Clinical and Mechanistic Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4143-844X","authenticated-orcid":false,"given":"Drago\u0219","family":"For\u021bofoiu","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4843-1005","authenticated-orcid":false,"given":"Victor-Mihai","family":"Sacerdo\u021bianu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Emmanuel","family":"\u0218erban","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4452-0991","authenticated-orcid":false,"given":"Petric\u0103","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8957-690X","authenticated-orcid":false,"given":"Ioana-Gabriela","family":"Dragne","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion","family":"Rogoveanu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-6138","authenticated-orcid":false,"given":"Mihail Virgil","family":"Boldeanu","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drago\u0219-Marian","family":"Popescu","sequence":"additional","affiliation":[{"name":"Department of Extreme Conditions Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristin-Constantin","family":"Vere","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3892\/mco.2025.2831","article-title":"Endocrine paraneoplastic syndromes in lung cancer: A call for clinical vigilance (Review)","volume":"22","author":"Koloutsou","year":"2025","journal-title":"Mol. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0300-595X(80)80032-6","article-title":"Ectopic hormone syndromes","volume":"9","author":"Imura","year":"1980","journal-title":"Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12020-018-1773-3","article-title":"Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms","volume":"64","author":"Daskalakis","year":"2019","journal-title":"Endocrine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e00471","DOI":"10.1002\/edm2.471","article-title":"A systematic review of literature on Insulin like growth factor 2 mediated hypoglycaemia in non islet cell tumours","volume":"7","author":"Ata","year":"2024","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"bvab157","DOI":"10.1210\/jendso\/bvab157","article-title":"Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years","volume":"5","author":"Sheehan","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_7","first-page":"1551","article-title":"Cancer-induced hypercalcemia","volume":"29","author":"Lumachi","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.25083\/rbl\/24.5\/813.819","article-title":"Paraneoplastic syndromes in digestive tumors: A review","volume":"24","author":"Draghici","year":"2019","journal-title":"Romanian Biotechnol. Lett."},{"key":"ref_9","first-page":"1","article-title":"Paraneoplastic syndromes in esophageal cancer\u2014A narrative review","volume":"6","author":"Ronan","year":"2021","journal-title":"Ann. Esophagus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1507\/endocrj.EJ12-0406","article-title":"Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: A case report and review of the literature","volume":"60","author":"Nakajima","year":"2013","journal-title":"Endocr. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102667","DOI":"10.1016\/j.amsu.2021.102667","article-title":"Hypercalcemia of malignancy in metastatic esophageal squamous cell carcinoma with simultaneous PTHrP and calcitriol overproduction: A case report with literature review","volume":"68","author":"Song","year":"2021","journal-title":"Ann. Med. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","article-title":"Cancer-associated hypercalcemia: Morbidity and mortality. Clinical experience in 126 treated patients","volume":"112","author":"Ralston","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: Causes and survival in 138 patients","volume":"100","author":"Donovan","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","first-page":"12","article-title":"Hypercalcemia of Malignancy and Colorectal Cancer","volume":"5","author":"Galindo","year":"2016","journal-title":"World J. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials","volume":"19","author":"Major","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e3756","DOI":"10.1210\/clinem\/dgaf107","article-title":"The Efficacy and Safety of Denosumab for Treating Hypercalcemia in Primary Hyperparathyroidism: A Retrospective Study","volume":"110","author":"Song","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1159\/000518316","article-title":"Paraneoplastic Cushing Syndrome in Gastrointestinal Neuroendocrine Tumour","volume":"14","author":"Mineur","year":"2021","journal-title":"Case Rep. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M","article-title":"Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center","volume":"71","author":"Newman","year":"1993","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome","volume":"367","author":"Bertagna","year":"2006","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic ACTH syndrome: Clinical features, diagnosis, management and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1530\/EJE-15-0968","article-title":"Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors","volume":"174","author":"Kamp","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-16-0809","article-title":"Prognostic factors in ectopic Cushing\u2019s syndrome due to neuroendocrine tumors: A multicenter study","volume":"176","author":"Cosaro","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pale\u0144 Tytko, J.E., Przybylik Mazurek, E.M., Rzepka, E.J., Pach, D.M., Sowa Staszczak, A.S., Gilis Januszewska, A., and Hubalewska Dydejczyk, A.B. (2020). Ectopic ACTH syndrome of different origin Diagnostic approach and clinical outcome. Experience of one Clinical Centre. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0242679"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"bcr2015211520","DOI":"10.1136\/bcr-2015-211520","article-title":"Possible ACTH-independent, cortisol-secreting and DHEA-secreting metastatic hepatocellular carcinoma causing Cushing\u2019s syndrome","volume":"2015","author":"Sacerdote","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_25","first-page":"20","article-title":"Late-onset ectopic ACTH syndrome in a patient with stable small bowel carcinoid tumor","volume":"2020","author":"Tsagarakis","year":"2020","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s42000-019-00163-z","article-title":"Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing\u2019s syndrome","volume":"19","author":"Lase","year":"2020","journal-title":"Hormones"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022308429992","article-title":"Medical therapy of Cushing\u2019s disease","volume":"5","author":"Nieman","year":"2002","journal-title":"Pituitary"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: Twenty years\u2019 experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Baev, V., Koppers-Lalic, D., and Costa-Silva, B. (2023). Liquid Biopsy: Current Status and Future Perspectives. Cancers, 15.","DOI":"10.3390\/cancers15123205"},{"key":"ref_30","first-page":"37","article-title":"Updates on the role of adrenal steroidogenesis inhibitors in Cushing\u2019s syndrome: A focus on recent developments","volume":"51","author":"Fleseriu","year":"2016","journal-title":"Endocrine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: A review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing\u2019s syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.beem.2016.02.009","article-title":"The syndrome of inappropriate antidiuresis (SIAD)","volume":"30","author":"Cuesta","year":"2016","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"The syndrome of inappropriate antidiuresis","volume":"356","author":"Ellison","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.ajkd.2011.08.029","article-title":"Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes","volume":"59","author":"Doshi","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"12993","DOI":"10.1038\/s41598-019-49601-3","article-title":"Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: The HYPNOSIS study","volume":"9","author":"Mariani","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1758835919877725","DOI":"10.1177\/1758835919877725","article-title":"Syndrome of inappropriate anti diuretic hormone secretion in cancer patients: Results of the first multicenter Italian study","volume":"27","author":"Berardi","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2169\/internalmedicine.35.280","article-title":"A rare case of ectopic antidiuretic hormone-producing pancreatic adenocarcinoma: New diagnostic approach","volume":"35","author":"Nagashima","year":"1996","journal-title":"Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1634\/theoncologist.2011-0400","article-title":"Diagnosis and management of hyponatremia in cancer patients","volume":"17","author":"Castillo","year":"2012","journal-title":"Oncologist"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2169\/internalmedicine.9048-17","article-title":"Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Mucosa-associated Lymphoid Tissue Lymphoma","volume":"56","author":"Shimizu","year":"2017","journal-title":"Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10388-018-0615-y","article-title":"Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin","volume":"15","author":"Shimada","year":"2018","journal-title":"Esophagus"},{"key":"ref_42","first-page":"786","article-title":"Diagnosis and management of hyponatremia: Expert panel recommendations","volume":"133","author":"Peri","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","article-title":"Non-peptide arginine-vasopressin antagonists: The vaptans","volume":"371","author":"Decaux","year":"2008","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1210\/jc.2013-3382","article-title":"Management of non-islet-cell tumor hypoglycemia: A clinical review","volume":"99","author":"Bodnar","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1677\/ERC-07-0161","article-title":"Non-islet cell tumour-induced hypoglycaemia: A review of the literature including two new cases","volume":"14","author":"Rikhof","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_47","first-page":"1359","article-title":"Hypoglycemia in cancer","volume":"367","author":"Cryer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1507\/endocrj.EJ17-0072","article-title":"Levels of glucose regulatory hormones in patients with non islet cell tumor hypoglycemia: Including a review of the literature","volume":"64","author":"Fukuda","year":"2017","journal-title":"Endocr. J."},{"key":"ref_49","first-page":"463","article-title":"A case of hepatocellular carcinoma with non-islet cell tumor hypoglycemia successfully managed with steroid therapy and transcatheter arterial embolization","volume":"12","author":"Kudo","year":"2019","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_50","first-page":"1361","article-title":"Successful treatment of a GIST-related hypoglycemia with imatinib: A case report and review of the literature","volume":"29","author":"Peker","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1172\/JCI39375","article-title":"Acromegaly pathogenesis and treatment","volume":"119","author":"Melmed","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0889-8529(18)30203-2","article-title":"Ectopic acromegaly","volume":"21","author":"Faglia","year":"1992","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_53","first-page":"933","article-title":"A case of paraneoplastic acromegaly due to ectopic GHRH secretion from a colonic carcinoma","volume":"61","author":"Yoshida","year":"2022","journal-title":"Intern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1210\/jc.2011-2930","article-title":"Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone releasing hormone (GHRH): A French nationwide series of 21 cases","volume":"97","author":"Garby","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Zendran, I., Gut, G., Ka\u0142u\u017cny, M., Zawadzka, K., and Bolanowski, M. (2022). Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.867965"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/annonc\/12.suppl_2.S89","article-title":"Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: Relevant clinical aspects","volume":"12","author":"Doga","year":"2001","journal-title":"Ann. Oncol."},{"key":"ref_57","first-page":"315","article-title":"Acromegaly: Clinical and therapeutic updates","volume":"71","author":"Colao","year":"2021","journal-title":"Endocrine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","article-title":"Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant","volume":"342","author":"Trainer","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1385\/ENDO:20:3:271","article-title":"Somatostatin analogs in medical treatment of acromegaly","volume":"20","author":"Racine","year":"2003","journal-title":"Endocrine"},{"key":"ref_60","first-page":"353","article-title":"Feminizing paraneoplastic syndrome associated with gastrointestinal malignancies","volume":"101","author":"Nockel","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0029-1211326","article-title":"Gynaecomastia in a patient with a hCG producing giant cell carcinoma of the lung","volume":"103","author":"Forst","year":"1995","journal-title":"Exp. Clin. Endocrinol. Diabetes."},{"key":"ref_62","first-page":"1369","article-title":"A case of advanced gastric cancer growing extramurally with gynecomastia and high hCG-beta serum level","volume":"37","author":"Arai","year":"2010","journal-title":"Gan Kagaku Ryoho Cancer Chemother."},{"key":"ref_63","first-page":"e260","article-title":"Gynecomastia as Unusual Presentation of Primary Choriocarcinoma of the Colon: A Case Report Literature Review","volume":"1","author":"Pizarro","year":"2015","journal-title":"AACE Clin. Case Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2018-00158","article-title":"Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease","volume":"40","author":"Grossmann","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/smrj.23","article-title":"Clinical Use of Aromatase Inhibitors in Adult Males","volume":"2","author":"Tan","year":"2014","journal-title":"Sex. Med. Rev."},{"key":"ref_66","first-page":"2161","article-title":"Paraneoplastic feminization and gynecomastia in hepatocellular carcinoma: A case report and review of literature","volume":"6","author":"Vale","year":"2018","journal-title":"Clin. Case Rep."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Burciu, C., Sirli, R., Bende, R., Vuletici, D., Miutescu, B., Moga, T., Bende, F., Popescu, A., Sporea, I., and Koppandi, O. (2024). Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study. Medicina, 60.","DOI":"10.3390\/medicina60040552"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Olsson, H., Bladstrom, A., and Alm, P. (2002). Male gynecomastia and risk for malignant tumours\u2014A cohort study. BMC Cancer, 2.","DOI":"10.1186\/1471-2407-2-26"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Song, M., Wang, H., Song, L., Tian, H., Ge, Q., Li, J., Zhu, Y., Li, J., Zhao, R., and Ji, H.L. (2014). Ectopic TSH-secreting pituitary tumor: A case report and review of prior cases. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-544"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00108-011-2920-6","article-title":"Ektope Hormonsekretion bei neuroendokrinen Tumoren [Ectopic hormone secretion by neuroendocrine tumors]","volume":"53","author":"Hubold","year":"2012","journal-title":"Internist"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1023\/A:1026623028794","article-title":"Esophageal small cell carcinoma with ectopic production of parathyroid hormone-related protein (PTHrp), secretin, and granulocyte colony-stimulating factor (G-CSF)","volume":"44","author":"Nagashima","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"ref_72","first-page":"2023","article-title":"Paraneoplastic endocrine syndromes","volume":"13","author":"Ariyoshi","year":"1986","journal-title":"Gan Kagaku Ryoho"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors","volume":"59","author":"Hope","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_74","first-page":"15","article-title":"PET radiomics in neuroendocrine tumors: A systematic review","volume":"9","author":"Sollini","year":"2021","journal-title":"Clin. Transl. Imaging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes: An update","volume":"25","author":"Graus","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MED.0000000000000247","article-title":"Novel targeted therapies in adrenocortical carcinoma","volume":"23","author":"Konda","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00024677-200504020-00003","article-title":"Pharmacologic management of Cushing syndrome: New targets for therapy","volume":"4","author":"Sonino","year":"2005","journal-title":"Treat. Endocrinol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4677\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:27:37Z","timestamp":1780399657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":77,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27114677"],"URL":"https:\/\/doi.org\/10.3390\/ijms27114677","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}